Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

Risk Stratification According to Midlife Physical Fitness in an Asymptomatic Population.

Palau P, Bayés-Genís A, Núñez J.

J Am Coll Cardiol. 2018 Dec 18;72(24):3230-3231. doi: 10.1016/j.jacc.2018.09.070. No abstract available.

PMID:
30545463
2.

Early effects of empagliflozin on exercise tolerance in patients with heart failure: A pilot study.

Núñez J, Palau P, Domínguez E, Mollar A, Núñez E, Ramón JM, Miñana G, Santas E, Fácila L, Górriz JL, Sanchis J, Bayés-Genís A.

Clin Cardiol. 2018 Apr;41(4):476-480. doi: 10.1002/clc.22899. Epub 2018 Apr 17.

3.

Changes in myocardial iron content following administration of intravenous iron (Myocardial-IRON): Study design.

Miñana G, Cardells I, Palau P, Llàcer P, Fácila L, Almenar L, López-Lereu MP, Monmeneu JV, Amiguet M, González J, Serrano A, Montagud V, López-Vilella R, Valero E, García-Blas S, Bodí V, de la Espriella-Juan R, Sanchis J, Chorro FJ, Bayés-Genís A, Núñez J; Myocardial-IRON Investigators.

Clin Cardiol. 2018 Jun;41(6):729-735. doi: 10.1002/clc.22956. Epub 2018 Jun 5.

4.

Heart Rate in Heart Failure With Preserved Ejection Fraction: Another Example of the Heterogeneity of This Syndrome.

Palau P, Domínguez E, Sanchis J, Bayés-Genis A, Núñez J.

JACC Heart Fail. 2018 Apr;6(4):350-351. doi: 10.1016/j.jchf.2017.12.003. No abstract available.

PMID:
29598943
5.

Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction.

Domínguez E, Palau P, Núñez E, Ramón JM, López L, Melero J, Bellver A, Santas E, Chorro FJ, Núñez J.

ESC Heart Fail. 2018 Aug;5(4):579-585. doi: 10.1002/ehf2.12281. Epub 2018 Mar 24.

6.

Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: The TRAINING-HF Trial.

Palau P, Domínguez E, López L, Ramón JM, Heredia R, González J, Santas E, Bodí V, Miñana G, Valero E, Mollar A, Bertomeu González V, Chorro FJ, Sanchis J, Lupón J, Bayés-Genís A, Núñez J.

Rev Esp Cardiol (Engl Ed). 2018 Mar 16. pii: S1885-5857(18)30038-0. doi: 10.1016/j.rec.2018.01.010. [Epub ahead of print] English, Spanish.

PMID:
29551699
7.

Early Sacubitril/Valsartan-driven Benefit on Exercise Capacity in Heart Failure With Reduced Ejection Fraction: A Pilot Study.

Palau P, Mollar A, Domínguez E, Sanchis J, Bayés-Genís A, Núñez J.

Rev Esp Cardiol (Engl Ed). 2019 Feb;72(2):167-169. doi: 10.1016/j.rec.2017.11.025. Epub 2018 Jan 17. English, Spanish. No abstract available.

PMID:
29373254
8.

Sacubitril/valsartan and short-term changes in the 6-minute walk test: A pilot study.

Beltrán P, Palau P, Domínguez E, Faraudo M, Núñez E, Guri O, Mollar A, Sanchis J, Bayés-Genís A, Núñez J.

Int J Cardiol. 2018 Feb 1;252:136-139. doi: 10.1016/j.ijcard.2017.10.074.

PMID:
29249422
9.

Clinical utility of cardiopulmonary exercise testing in patients with heart failure with preserved ejection fraction.

Palau P, Domínguez E, Núñez J.

Eur J Heart Fail. 2018 Feb;20(2):409-410. doi: 10.1002/ejhf.1066. Epub 2017 Nov 16. No abstract available.

10.

Peak Exercise Oxygen Uptake Predicts Recurrent Admissions in Heart Failure With Preserved Ejection Fraction.

Palau P, Domínguez E, Núñez E, Ramón JM, López L, Melero J, Sanchis J, Bellver A, Santas E, Bayes-Genis A, Chorro FJ, Núñez J.

Rev Esp Cardiol (Engl Ed). 2018 Apr;71(4):250-256. doi: 10.1016/j.rec.2017.05.022. Epub 2017 Jun 27. English, Spanish.

PMID:
28666951
11.

Inspiratory Muscle Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction.

Palau P, Domínguez E, Núñez E, Ramón JM, López L, Melero J, Bellver A, Chorro FJ, Bodí V, Bayés-Genis A, Sanchis J, Núñez J.

J Card Fail. 2017 Jun;23(6):480-484. doi: 10.1016/j.cardfail.2017.04.016. Epub 2017 Apr 24.

PMID:
28449951
12.

Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design.

García-Blas S, Bonanad C, Llàcer P, Ventura S, Núñez JM, Sánchez R, Chamorro C, Fácila L, de la Espriella R, Vaquer JM, Cordero A, Roqué M, Ortiz V, Racugno P, Bodí V, Valero E, Santas E, Moreno MDC, Miñana G, Carratalá A, Bondanza L, Payá A, Cardells I, Heredia R, Pellicer M, Valls G, Palau P, Bosch MJ, Raso R, Sánchez A, Bertomeu-González V, Bertomeu-Martínez V, Montagud-Balaguer V, Albiach-Montañana C, Pendás-Meneau J, Marcaida G, Cervantes-García S, San Antonio R, de Mingo E, Chorro FJ, Sanchis J, Núñez J; IMPROVE-HF Investigators.

Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1067-1073. doi: 10.1016/j.rec.2017.02.028. Epub 2017 Mar 22. English, Spanish.

PMID:
28341415
13.

Burden of Recurrent Hospitalizations Following an Admission for Acute Heart Failure: Preserved Versus Reduced Ejection Fraction.

Santas E, Valero E, Mollar A, García-Blas S, Palau P, Miñana G, Núñez E, Sanchis J, Chorro FJ, Núñez J.

Rev Esp Cardiol (Engl Ed). 2017 Apr;70(4):239-246. doi: 10.1016/j.rec.2016.06.021. Epub 2016 Nov 3. English, Spanish.

PMID:
27816423
14.

Carbohydrate Antigen-125-Guided Therapy in Acute Heart Failure: CHANCE-HF: A Randomized Study.

Núñez J, Llàcer P, Bertomeu-González V, Bosch MJ, Merlos P, García-Blas S, Montagud V, Bodí V, Bertomeu-Martínez V, Pedrosa V, Mendizábal A, Cordero A, Gallego J, Palau P, Miñana G, Santas E, Morell S, Llàcer A, Chorro FJ, Sanchis J, Fácila L; CHANCE-HF Investigators.

JACC Heart Fail. 2016 Nov;4(11):833-843. doi: 10.1016/j.jchf.2016.06.007. Epub 2016 Aug 10.

15.

Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: Rationale and Study Design of a Prospective Randomized Controlled Trial.

Palau P, Domínguez E, López L, Heredia R, González J, Ramón JM, Serra P, Santas E, Bodi V, Sanchis J, Chorro FJ, Núñez J.

Clin Cardiol. 2016 Aug;39(8):433-9. doi: 10.1002/clc.22555. Epub 2016 Aug 2.

16.

Plasma neutrophil gelatinase-associated lipocalin and long-term mortality in patients with acute heart failure and normal renal function.

Miñana G, Rumiz E, Palau P, Valero E, Bodí V, Núñez E, Sanchis J, Núñez J.

Int J Cardiol. 2016 Jul 1;214:51-3. doi: 10.1016/j.ijcard.2016.03.089. Epub 2016 Mar 25. No abstract available.

PMID:
27057976
17.

Iron deficiency and functional capacity in patients with advanced heart failure with preserved ejection fraction.

Núñez J, Domínguez E, Ramón JM, Núñez E, Sanchis J, Santas E, Heredia R, González J, Miñana G, López L, Chorro FJ, Palau P.

Int J Cardiol. 2016 Mar 15;207:365-7. doi: 10.1016/j.ijcard.2016.01.187. Epub 2016 Jan 14. No abstract available.

PMID:
26820369
18.

Isolated Partial Congenital Absence of the Pericardium: A Familial Presentation.

Palau P, Domínguez E, García-González P, Gallego J, Bosch MJ, Sieso E.

Can J Cardiol. 2016 Aug;32(8):1039.e1-2. doi: 10.1016/j.cjca.2015.09.001. Epub 2015 Sep 12.

PMID:
26774230
19.

Six-minute walk test in moderate to severe heart failure with preserved ejection fraction: Useful for functional capacity assessment?

Palau P, Domínguez E, Núñez E, Sanchis J, Santas E, Núñez J.

Int J Cardiol. 2016 Jan 15;203:800-2. doi: 10.1016/j.ijcard.2015.11.074. Epub 2015 Nov 10. No abstract available.

PMID:
26595788
20.

Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure.

Núñez J, Rabinovich GA, Sandino J, Mainar L, Palau P, Santas E, Villanueva MP, Núñez E, Bodí V, Chorro FJ, Miñana G, Sanchis J.

PLoS One. 2015 Apr 13;10(4):e0122360. doi: 10.1371/journal.pone.0122360. eCollection 2015.

Supplemental Content

Support Center